Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Research and Markets: Next Generation Sequencing (NGS) Report 2013: How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

10/10/2013 | 10:30am US/Eastern

Research and Markets (http://www.researchandmarkets.com/research/ddm37b/next_generation) has announced the addition of the "Next Generation Sequencing Report 2013" report to their offering.

The Next Generation Sequencing market is poised to reach $4.4B in 2018!

How are NGS Technologies Revolutionizing the Way we Think About Healthcare?

NGS technologies drive the way toward personalized medicine

Our analysis provides 2013-2018 market data, along with player market shares at both equipment and consumable levels. Moreover, positioning strategy of each supplier has been analyzed in the document.

Discover the NGS market's complex organization, splitted in four segments

The market segmentation is a tool used to provide a vision of the market. Based on technical and economic criteria, fours segments have been identified: research, forensics, diagnostics and consumer.

Until recently, uses of Next Generation Sequencing tools were limited to research (human whole genome, exome, small genome, targeted, transcriptome, RNA profiling, chIP-Seq, metagenomics).

Nowadays, NGS technologies have found applications mainly in two fields: clinical diagnostics and forensics.

Our investigation describes both current and future applications.

Next Generation Sequencing technologies overview

  • In April 2003, human genome project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B!
  • Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the human genome project to the Next Generation Sequencing technologies available today.
  • By sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10, along with a steep price reduction.
  • The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world.
  • Today, based on these new technologies, we can sequence the whole human genome in less than three hours with one laboratory technician and a total cost around $1000.
  • Technologies under development are poised to extend the boundaries with a targeted sequencing cost of $100.
  • All technologies currently in use and those under development are presented in our report. Benchmarking is also presented for eight different sequencing applications.

New opportunities arise for cartridge makers

  • The wide adoption of NGS technology has changed the way NGS suppliers are generating revenue. A shift occurred in the sales mix, moving from instruments to consumables which have a higher gross margin than instruments.
  • This leads to an increase in revenue based on consumable sales.
  • The number of NGS Platforms used worldwide will exploded in the next several years and the run time will continue to decrease. Therefore, the market of NGS consumables will follow.

Report's key features

- 2013-2018 Next Generation Sequencing equipment market

- 2013-2018 Next Generation Sequencing consumable market

- Market segmentation which highlights current and future applications

- Overview of sequencing technologies and cartridges associated

- Detailed supply chain and business model analysis highlighting the major changes expected over next few years

- Company profiles of the main players

Report objectives

- Provide an overview of global NGS market both at equipment and consumable levels.

- Present main players and technologies involved

- Analyze both technical and market trends

- Focus on microfluidic consumable cartridges used for genome testing

- Supply Chain analysis

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market data

4. Market segmentation

5. Next Generation Sequencing technologies overview

6. Value chain and supply chain

7. Market trends and challenges

8. Company profiles

Companies Mentioned

- 23andme

- Affymetrix

- Azco Biotech Inc

- Baseclear

- Base 4

- BGI-Shenzhen

- Completegenomics

- DNAvision

- Genia Technologies

- Genapsys

- GnuBIO

- Hitachi

- Illumina

- LaserGen

- NabSys

- Noblegen Biosciences

- Oxford Nanopore Technologies

- Pacific Biosciences

- Qiagen

- Roche 454

- Stratos Genomics Inc.

- Thermo Fisher Scientific

- TSMC

For more information visit http://www.researchandmarkets.com/research/ddm37b/next_generation

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


© Business Wire 2013
React to this article
Latest news
Date Title
10:30a EUROGROUP TO DISCUSS GREECE ON CALL AT 1700 GMT : sources
10:30aDJBOND REPORT : Treasury Yields Edge Higher As Greek Saga Unfolds
10:30a SEI INVESTMENTS : Wealth Platform(SM) Achieves Recognition of Financial Stability
10:29a Osteopathic Manipulative Therapy Significantly Improves Low Back Pain in Postpartum Women
10:28a GRUPA LOTOS : Conclusion of an agreement for financing of the EFRA Project
10:28a REXAM : Form 8.3 -
10:28a CHINA BIO MED REGENERATION TECHNOLOGY : Unusual Share Price Movements
10:28a EUROPEAN COMMISSION DIRECTORATE GENERAL FOR TAXA : Customs: EU and China signed a joint statement on Authorised Economic Operators
10:28a FAR EAST : COMPLETION OF THE DISCLOSEABLE TRANSACTION: ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF COAST HOLDINGS LIMITED (in PDF)
10:28a BIO LIGHT ISRAELI LIFE SCIENCES INV : EU CE Mark for CellDetect Non-Invasive Test for Detecting Recurrence of Bladder Cancer
Latest news
Advertisement
Hot News 
DOMINO PRINTING SCIENCES : Uhlmann and Domino in partnership as suppliers of choice for serialised pharmaceutical printing systems
HARBOURVEST HVGPE : Press Release 31 May 2015 Estimated Net Asset Value and Interim Management Statement
HMS BERGBAU : very satisfied with financial year 2014 (DGAP News)
BLUE STAR CAPITAL : Reports Loss In First Half
Signal Genetics Announces Master Service Agreement
Most Read News
01:34a MANCHESTER UNITED : Ramos: i'm mad for united
06/29 Microsoft hands display ads to AOL, maps to Uber
06/29DJBHP Billiton Shifts Responsibility for Potash Unit
06/29 DEUTSCHE LUFTHANSA : Lufthansa strikes postponed until mid-July, union says
06/29DJCelgene to Pay Juno $1 Billion as Part of 10-Year Collaboration
Most recommended articles
10:21a Greek opposition leader says wages, pensions at risk in referendum
10:20aDJSchnitzer Steel Swings to a Loss as Revenue Slides
10:16aDJOil Prices Rise as Investors Watch Iran Nuclear Talks
10:15aDJNIELSEN NV : Press Release : The Conference Board Consumer Confidence Index(R) Increases Again
10:15aDJMay Construction Spending Seen Up 0.5%--Data Week Ahead